Back to search

Dublin City University

Copper(II)-based chemical nucleases as new therapeutics targeting nucleic acids

Abstract

dc:description.abstract

Metallodrugs are well-established in the field of genotoxic intervention, including anticancer clinical standards iron(II)-bleomycin and platinum agents. Multidrug resistance (MDR) is a growing clinical pitfall for new and existing therapeutics, necessitating new avenues of binding and genotoxicity. Herein, we explore copper(II) chemical nuclease binding and damage to nucleic acids through interactions distinct from clinical standards. First, the artificial metallo-nuclease (AMN) Cu-Oda was explored by multilayered analytical techniques to better understand a localised “Z-like” DNA induced by drug exposure. Circular dichroism (CD) spectroscopy correlated “Zlike” DNA to H-bonding, suggesting non-covalent electrostatic interactions. Further single-molecule analysis and atomic force microscopy (AFM) corroborated a Cu-Oda dependent perturbation in DNA helicity. Finally, cytotoxicity of Cu-Oda and its role in repair pathways were explored in patientderived blood cells, platinum resistant breast cancer cells, and murine xenograft MDA-MB-231 models. The data showed Cu-Oda could provide an alternative first-line treatment to platinum resistant TNBC, or second-line treatment to refractory cancers. This was followed by further structural studies using Cu-Oda congeners to probe Cu(II)-Cu(II) cooperativity in its multimodal binding. Interestingly, analogue Cu-Dda correlated increased linker length with improved AMN activity by electrophoretic and AFM studies. The data herein provides an insight into the perturbations to DNA helicity preceding localised “Z-like” DNA, and how this might inform future anticancer AMNs independent of classical repair pathways. Next, copper(II) complexes were targeted in an antisense context with sequence-selectivity through click conjugation to an antisense oligonucleotide (ASO) as oxidative RIBOTACs. Despite strong RNA affinity, poor oxidative cleavage suggested the RNA secondary structure is important to its susceptibility to oxidative cleavage. Finally, second-generation click-functional ASOs were rationally designed against KRAS mRNA for encapsulation into HAWC peptide nanoparticles, with future applications in metallodrug hybrids. Good cellular internalisation and knockdown of KRAS mRNA demonstrate how nanoparticle technology overcomes clinical limitations of cellular delivery.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
Dublin City University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bain, Conor

Subjects

dc:subject × 3

Rights

Language dc:language
en

Chain of custody

source
Harvested from
Dublin City University
Base URL
doras.dcu.ie/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Bain, Conor. Copper(II)-based chemical nucleases as new therapeutics targeting nucleic acids. doctoral thesis, Dublin City University, 2026.